Verona Pharma plc Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Verona Pharma plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Verona Pharma plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$70.8M, a 704% decline year-over-year.
  • Verona Pharma plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$125M, a 143% decline year-over-year.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2023 was -$54.4M, a 20.9% increase from 2022.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2022 was -$68.7M, a 23.6% decline from 2021.
  • Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2021 was -$55.6M, a 14.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$54.4M +$14.3M +20.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$68.7M -$13.1M -23.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$55.6M +$9.58M +14.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$65.1M -$24.6M -60.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$40.6M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.